Article
Outcomes of Salvage Fractionated Reirradiation Combined With Bevacizumab for Recurrent High-grade Gliomas That Progressed After Treatment With Bevacizumab
2021-01-18
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: This study evaluated the outcomes of reirradiation combined with bevacizumab (Bev) for patients with recurrent high-grade gliomas that progressed after treatment with Bev.<bold>Methods</bold>: Between January 2015 and September 2019, 14 patients who experienced progression after Bev treatment were treated with reirradiation consisting of 25 Gy in five fractions...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c7cda8e2-1464-5f38-ad89-51a315548078
- DOI
- 10.21203/rs.3.rs-147697/v1
